Some GLP-1 injections recalled due to 'lack of assurance of sterility'
Apothecary Pharma, a compounding pharmacy, voluntarily recalled 22 vials of Tirzepatide injections due to a "lack of assurance of sterility," according to the official announcement.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.latimes.com — the content belongs to Los Angeles Times.
